Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Bayer Pushes Congress to Grant Immunity For Roundup Cancer Lawsuits in Next Farm Bill Proposed legislation that would enact uniform pesticide labeling may prevent failure to warn lawsuits from being pursued under state laws, which may have more stringent label standards than the EPA. July 30, 2024 Irvin Jackson Add Your Comments Bayer is reportedly lobbying Congress to add provisions to the latest version of the Farm Bill, which is intended to address regulations and funding for the nation’s agricultural industry. However the pesticide manufacturer is urging lawmakers to include provisions that may shield the company from future Roundup lawsuits over failure to warn about the risk of non-Hodgkin’s lymphoma, with some reports indicating Bayer helped write the first draft of the federal bill currently under consideration. Roundup has been widely used for decades in the agricultural industry, as well as for residential purposes as a weed killer, containing glyphosate as the active ingredient. Although it has been marketed as safe for humans, there is now growing research highlighting serious health concerns for users. In 2015, the World Health Organization’s International Agency for Research on Cancer (IARC), classified glyphosate as a probable cancer-causing agent. Since then, a number of restrictions have been imposed on Roundup use in various parts of the world, due to concerns of an increased risk of non-Hodgkin’s lymphoma and other cancers linked to the weed killer’s use. As a result of the failure to warn about the potential side effects of glyphosate, Bayer and its Monsanto subsidiary have faced more than 120,000 Roundup non-Hodgkins lymphona lawsuits over the past decade, each raising similar allegations that users developed cancer after using the product in an agricultural setting or around the home. Although Bayer and it’s Monsanto unit have paid more than $10 billion in Roundup settlements, the manufacturers continue face thousands of active lawsuits pending throughout the U.S. court system, and new claims continue to be filed as former users of the weed killer develop the blood cancer. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION To artificially limit its liability for withholding information about the Roundup non-Hodgkins lymphoma risks for decades, Bayer has been pushing for new legislation that would grant the company immunity to such lawsuits at both the state and federal level. According to various media reports, the company has now focused its efforts on the U.S. Farm Bill; a package of legislation passed once every five years that affects how food is grown, which agricultural programs the government will support, and new regulations on the industry. The draft version of the Farm Bill (PDF) includes a provision, reportedly drafted by Bayer, which calls for the federal government to establish uniform pesticide labeling laws, which would prevent states from having their own laws to protect citizens from Roundup and other weed and pest killers. The provision would stipulate that the company is immune to litigation if its labels meet the requirements of the U.S. Environmental Protection Agency (EPA). Despite widespread concerns about glyphosate, the active ingredient in Roundup, throughout the scientific community, and the World Health Organization’s determination that it probably causes cancer, the EPA, to date, has deemed glyphosate to be safe. Other states, such as California, have said the weed killer represents a potential health threat, and have ordered cancer warnings be added to the labels, which Bayer has resisted through court filings. Bayer has also lobbied for such protections in major agricultural states. Earlier this year, several Idaho lawmakers introduced legislation in that state which would make it harder for citizens injured by Roundup exposure to file claims against the company. Officials from the company testified in support of the Idaho measure in February. It is unclear, particularly in an election year, when or in what shape the federal Farm Bill will be passed. However, Bayer officials have rejected claims that the Farm Bill addition would shield the company from all liability, saying much of that is still in the hands of the court. August 2024 Roundup Lawsuit Update After failing to secure dismissal of Roundup lawsuits under federal preemption arguments previously raised, which were rejected earlier this year by the U.S. Court of Appeals for the Eleventh Circuit, hundreds of claims brought at the federal court level are currently being prepared for trials nationwide. However, most of the U.S. litigation is pending in state courts, including Missouri, Pennsylvania, New Jersey and California, where a series of non-Hodgkin’s lymphoma lawsuits are already scheduled to go before juries in the coming months. Although Bayer continues to defend the safety of glyphosate, the company has failed to establish that it can consistently defend the safety of the herbicide at trial, suffering a string of massive losses in state court trials over the past year, including the largest Roundup lawsuit verdict to date, $2.2 billion, handed down by a Pennsylvania state court jury in January. It was later reduced to $400 million. That verdict was preceded by a $1.5 billion verdict in November 2023, and a slew of others plaintiff victories last year. To limit liability from the Roundup failure to warn lawsuits, Bayer has announced that it will remove the active ingredient glyphosate from consumer products, while keeping the formulation for large agricultural users. However, it is still expected that Bayer will continue to face a steady stream of trials for years to come. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Bayer, Cancer, Congress, Herbicide, Idaho, Monsanto, Pesticide, Roundup, Weed Killer Image Credit: Sundry Photography More Roundup Lawsuit Stories Bayer’s Roundup Lawsuit Payouts Result in Another $1.37B in Reserves August 4, 2025 Roundup Non-Hodgkin’s Lymphoma Lawsuit Remanded From MDL for Trial July 25, 2025 New Study Appears To Confirm Link Between Roundup and Cancer July 7, 2025 0 Comments CommentsThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (Posted: today) Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025) MDL Sought for Lyft Lawsuits Over Sexual Assaults by Drivers (Posted: yesterday) A group of plaintiffs are asking a panel of federal judges to consolidate all Lyft lawsuits involving driver sexual assaults against passengers before one judge as part of a Lyft MDL. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITJury Finds Uber Failed To Protect Passengers, But Is Not Liable for Sexual Assault (10/01/2025)Lyft Sexual Assault Lawsuit Alleges Problems With Predatory Drivers Were Known for Years (09/25/2025)Two Uber Sexual Assault Bellwether Trials To Be Held in North Carolina (09/22/2025) Breast Mesh Problems Prompted FDA Warnings Over Off-Label Use (Posted: 2 days ago) Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (Posted: today) Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)
MDL Sought for Lyft Lawsuits Over Sexual Assaults by Drivers (Posted: yesterday) A group of plaintiffs are asking a panel of federal judges to consolidate all Lyft lawsuits involving driver sexual assaults against passengers before one judge as part of a Lyft MDL. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITJury Finds Uber Failed To Protect Passengers, But Is Not Liable for Sexual Assault (10/01/2025)Lyft Sexual Assault Lawsuit Alleges Problems With Predatory Drivers Were Known for Years (09/25/2025)Two Uber Sexual Assault Bellwether Trials To Be Held in North Carolina (09/22/2025)
Breast Mesh Problems Prompted FDA Warnings Over Off-Label Use (Posted: 2 days ago) Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)